[Medical treatment of chronic cholestasis: ursodeoxycholic acid].
作者信息
Linares Rodríguez A
机构信息
Servicio de Aparato Digestivo, Hospital Central de Asturias, Celestino Villamil.
出版信息
Gastroenterol Hepatol. 2000 Feb;23 Suppl 1:24-38.
PMID:11968340
Abstract
摘要
相似文献
1
[Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Gastroenterol Hepatol. 2000 Feb;23 Suppl 1:24-38.
2
3
[Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Tidsskr Nor Laegeforen. 1997 Sep 30;117(23):3370-3.
4
New therapeutical indications of ursodeoxycholic acid.
Rom J Gastroenterol. 2005 Sep;14(3):259-66.
5
[Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
MMW Fortschr Med. 2007 May 24;149(21):49.
6
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S9-17.
7
Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
Clin Res Hepatol Gastroenterol. 2012 Sep;36 Suppl 1:S1. doi: 10.1016/S2210-7401(12)70014-1.
8
[Treatment of cholestatic liver disease].
Rev Med Chir Soc Med Nat Iasi. 2003 Oct-Dec;107(4):733-6.
9
[Primary biliary cirrhosis and ursodeoxycholic acid therapy].
Nihon Naika Gakkai Zasshi. 1996 Mar 10;85(3):399-403.
10
[Treatment of cholestatic liver diseases].
Duodecim. 2003;119(6):533-9.
Zotero 插件